DLX5

DLX5

Target · Homeobox transcription factor

DLX5 Distal-less homeobox 5 · Homeobox protein DLX-5

DLX5 (distal-less homeobox 5) is a nuclear homeobox transcription factor of the distal-less family that contributes to bone development. It acts as a BMP-responsive activator of osteoblast differentiation and also supports chondrogenesis in the endochondral skeleton. Browse Assay Genie's current range of DLX5 research reagents below, or read on for the biology behind the target.

Nuclear proteinHomeobox transcription factorOsteoblast differentiation driver
289 aa
Protein length
~32 kDa
Molecular weight
7q21.3
Gene locus
Distal-less
Homeobox family
Target information

What is DLX5 (distal-less homeobox 5)?

DLX5 is a transcription factor involved in bone development. It acts as an immediate early, BMP-responsive transcriptional activator that is essential for osteoblast differentiation. During this process it stimulates ALPL promoter activity in a RUNX2-independent manner, and it also stimulates SP7 promoter activity. It binds the homeodomain-response element of the ALPL and SP7 promoters, and it requires the 5'-TAATTA-3' consensus sequence for DNA binding.

Beyond osteoblasts, DLX5 promotes cell proliferation by up-regulating MYC promoter activity, and it binds to the MYC promoter. It is also a positive regulator of both chondrogenesis and chondrocyte hypertrophy in the endochondral skeleton. The DLX5 protein is localised to the nucleus, in keeping with its role in gene regulation. It belongs to the distal-less homeobox family, and mouse and rat each have a Dlx5 ortholog.

The DLX5 gene encodes a member of a homeobox gene family similar to the Drosophila distal-less gene. HGNC previously listed the name as distal-less homeo box 5. According to the NCBI Gene summary, the encoded protein may play a role in bone development and fracture healing. The gene lies in a tail-to-tail configuration with another family member on the long arm of chromosome 7, and mutation in this region may be associated with split-hand/split-foot malformation. This makes DLX5 a useful focus for studies of skeletal development, osteogenic signalling and limb malformation.

Osteoblast differentiation

DLX5 is an essential BMP-responsive activator of osteoblast differentiation and drives ALPL and SP7 promoter activity.

Chondrogenesis and cartilage

DLX5 positively regulates chondrogenesis and chondrocyte hypertrophy in the endochondral skeleton.

Fracture healing studies

The NCBI Gene summary notes that DLX5 may play a role in bone development and fracture healing.

Limb malformation research

Mutation at the DLX5 locus may be associated with split-hand/split-foot malformation, linking it to limb development.

Background

DLX5 frequently asked questions

What does DLX5 do?

DLX5 is a nuclear transcription factor involved in bone development. It is an immediate early BMP-responsive activator needed for osteoblast differentiation, stimulating ALPL and SP7 promoters. It also up-regulates MYC promoter activity to promote proliferation, and it positively regulates chondrogenesis and chondrocyte hypertrophy.

What is DLX5 also called?

The official name is distal-less homeobox 5, and the previous HGNC name was distal-less homeo box 5. UniProt names the protein Homeobox protein DLX-5. No other aliases or previous symbols are listed, so searches for the DLX5 gene or protein generally use these names.

Is DLX5 conserved and linked to disease?

DLX5 is related to the Drosophila distal-less gene, and mouse and rat both have a Dlx5 ortholog. Mutation at this locus on chromosome 7 may be associated with split-hand/split-foot malformation. Check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other distal-less homeobox family members with products at Assay Genie.

Gene and protein annotations from HGNC, NCBI Gene and UniProt P56178; product specifications from Assay Genie datasheets.

DLX5 Product listing